{"id":"https://openalex.org/W3000299679","doi":"https://doi.org/10.1016/j.bbrc.2019.12.094","title":"Identification of a selective DDX3X inhibitor with newly developed quantitative high-throughput RNA helicase assays","display_name":"Identification of a selective DDX3X inhibitor with newly developed quantitative high-throughput RNA helicase assays","alternate_titles":[],"publication_year":2020,"publication_date":"2020-01-15","ids":{"openalex":"https://openalex.org/W3000299679","doi":"https://doi.org/10.1016/j.bbrc.2019.12.094","mag":"3000299679","pmid":"https://pubmed.ncbi.nlm.nih.gov/31954521"},"language":"en","primary_location":{"id":"doi:10.1016/j.bbrc.2019.12.094","doi":"https://doi.org/10.1016/j.bbrc.2019.12.094","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bbrc.2019.12.094","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0006291X20300310/pdf","source":{"id":"https://openalex.org/S151589183","display_name":"Biochemical and Biophysical Research Communications","issn_l":"0006-291X","issn":["0006-291X","1090-2104"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biochemical and Biophysical Research Communications","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3000299679"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.sciencedirect.com/science/article/pii/S0006291X20300310/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113824666","display_name":"Shoichi Nakao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shoichi Nakao","raw_affiliation_strings":["Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043028692","display_name":"Masahiro Nogami","orcid":"https://orcid.org/0000-0002-7027-4766","observed_orcids":["https://orcid.org/0000-0002-7027-4766"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masahiro Nogami","raw_affiliation_strings":["Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070735482","display_name":"Misa Iwatani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Misa Iwatani","raw_affiliation_strings":["Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011550267","display_name":"Toshihiro Imaeda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshihiro Imaeda","raw_affiliation_strings":["Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100617641","display_name":"Masahiro Ito","orcid":"https://orcid.org/0000-0001-5965-535X","observed_orcids":["https://orcid.org/0000-0001-5965-535X"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masahiro Ito","raw_affiliation_strings":["Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101700639","display_name":"Toshio Tanaka","orcid":"https://orcid.org/0000-0002-8213-383X","observed_orcids":["https://orcid.org/0000-0002-8213-383X"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshio Tanaka","raw_affiliation_strings":["Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077315674","display_name":"Michiko Tawada","orcid":"https://orcid.org/0000-0002-1349-0059","observed_orcids":["https://orcid.org/0000-0002-1349-0059"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Michiko Tawada","raw_affiliation_strings":["Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070379525","display_name":"Satoshi Endo","orcid":"https://orcid.org/0000-0002-8477-5553","observed_orcids":["https://orcid.org/0000-0002-8477-5553"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Satoshi Endo","raw_affiliation_strings":["Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021826916","display_name":"Douglas R. Cary","orcid":"https://orcid.org/0000-0003-3940-6078","observed_orcids":["https://orcid.org/0000-0003-3940-6078"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Douglas R. Cary","raw_affiliation_strings":["Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061826248","display_name":"Momoko Ohori","orcid":"https://orcid.org/0000-0002-4504-6032","observed_orcids":["https://orcid.org/0000-0002-4504-6032"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Momoko Ohori","raw_affiliation_strings":["Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037570394","display_name":"Yasuhiro Imaeda","orcid":"https://orcid.org/0000-0002-3173-9751","observed_orcids":["https://orcid.org/0000-0002-3173-9751"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasuhiro Imaeda","raw_affiliation_strings":["Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084346121","display_name":"Tomohiro Kawamoto","orcid":"https://orcid.org/0000-0002-2985-5948","observed_orcids":["https://orcid.org/0000-0002-2985-5948"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomohiro Kawamoto","raw_affiliation_strings":["Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074271128","display_name":"Samuel A. J. R. Aparicio","orcid":"https://orcid.org/0000-0002-0487-9599","observed_orcids":["https://orcid.org/0000-0002-0487-9599"]},"institutions":[{"id":"https://openalex.org/I1289530486","display_name":"BC Cancer Agency","ror":"https://ror.org/03sfybe47","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1289530486"]},{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Samuel Aparicio","raw_affiliation_strings":["Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC, V5Z 1L3, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, V6T 2B5, Canada","Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC, V5Z 1L3, Canada","Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, V6T 2B5, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC, V5Z 1L3, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, V6T 2B5, Canada","institution_ids":["https://openalex.org/I1289530486","https://openalex.org/I141945490"]},{"raw_affiliation_string":"Department of Molecular Oncology, BC Cancer Agency, Vancouver, BC, V5Z 1L3, Canada","institution_ids":["https://openalex.org/I1289530486"]},{"raw_affiliation_string":"Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, V6T 2B5, Canada","institution_ids":["https://openalex.org/I141945490"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036856096","display_name":"Atsushi Nakanishi","orcid":"https://orcid.org/0000-0002-5939-8530","observed_orcids":["https://orcid.org/0000-0002-5939-8530"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Atsushi Nakanishi","raw_affiliation_strings":["Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086186800","display_name":"Shinsuke Araki","orcid":"https://orcid.org/0000-0002-9936-1417","observed_orcids":["https://orcid.org/0000-0002-9936-1417"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Shinsuke Araki","raw_affiliation_strings":["Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan. Electronic address: shinsuke.araki@takeda.com","Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan. Electronic address: shinsuke.araki@takeda.com","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan","institution_ids":["https://openalex.org/I44892455"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5086186800"],"corresponding_institution_ids":["https://openalex.org/I44892455"],"apc_list":{"value":2450,"currency":"USD","value_usd":2450},"apc_paid":{"value":2450,"currency":"USD","value_usd":2450},"fwci":0.669,"has_fulltext":true,"cited_by_count":15,"citation_normalized_percentile":{"value":0.59777147,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"523","issue":"3","first_page":"795","last_page":"801"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10604","display_name":"RNA Research and Splicing","score":0.6958000063896179,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10604","display_name":"RNA Research and Splicing","score":0.6958000063896179,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10521","display_name":"RNA and protein synthesis mechanisms","score":0.20649999380111694,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10432","display_name":"DNA and Nucleic Acid Chemistry","score":0.01679999940097332,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ddx3x","display_name":"DDX3X","score":0.9419999718666077},{"id":"https://openalex.org/keywords/eif4a3","display_name":"EIF4A3","score":0.8930000066757202},{"id":"https://openalex.org/keywords/dead-box-rna-helicase","display_name":"DEAD-box RNA helicase","score":0.9819999933242798},{"id":"https://openalex.org/keywords/allosteric-inhibitors","display_name":"allosteric inhibitors","score":0.8349999785423279},{"id":"https://openalex.org/keywords/atpase-inhibition","display_name":"ATPase inhibition","score":0.7379999756813049},{"id":"https://openalex.org/keywords/high-throughput-screening","display_name":"high-throughput screening","score":0.925000011920929},{"id":"https://openalex.org/keywords/small-molecule-inhibitors","display_name":"small molecule inhibitors","score":0.8330000042915344},{"id":"https://openalex.org/keywords/cancer-therapeutics","display_name":"cancer therapeutics","score":0.7409999966621399}],"concepts":[{"id":"https://openalex.org/C68592252","wikidata":"https://www.wikidata.org/wiki/Q17913854","display_name":"RNA Helicase A","level":5,"score":0.9063631296157837},{"id":"https://openalex.org/C161223559","wikidata":"https://www.wikidata.org/wiki/Q138864","display_name":"Helicase","level":4,"score":0.8727934956550598},{"id":"https://openalex.org/C2779568538","wikidata":"https://www.wikidata.org/wiki/Q99526845","display_name":"DEAD box","level":5,"score":0.6481297612190247},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6406009197235107},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.5840786695480347},{"id":"https://openalex.org/C99348085","wikidata":"https://www.wikidata.org/wiki/Q5323174","display_name":"eIF4A","level":5,"score":0.5778447985649109},{"id":"https://openalex.org/C97154109","wikidata":"https://www.wikidata.org/wiki/Q906570","display_name":"Eukaryotic initiation factor","level":5,"score":0.4668087959289551},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3556610345840454},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.32516470551490784},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.32419800758361816},{"id":"https://openalex.org/C88478588","wikidata":"https://www.wikidata.org/wiki/Q42244","display_name":"Ribosome","level":4,"score":0.21373948454856873},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1452779769897461}],"mesh":[{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D039601","descriptor_name":"Eukaryotic Initiation Factor-4A","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D039601","descriptor_name":"Eukaryotic Initiation Factor-4A","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D053487","descriptor_name":"DEAD-box RNA Helicases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D053487","descriptor_name":"DEAD-box RNA Helicases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D054852","descriptor_name":"Small Molecule Libraries","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D054852","descriptor_name":"Small Molecule Libraries","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D057075","descriptor_name":"Enzyme Assays","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D057166","descriptor_name":"High-Throughput Screening Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.bbrc.2019.12.094","doi":"https://doi.org/10.1016/j.bbrc.2019.12.094","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bbrc.2019.12.094","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0006291X20300310/pdf","source":{"id":"https://openalex.org/S151589183","display_name":"Biochemical and Biophysical Research Communications","issn_l":"0006-291X","issn":["0006-291X","1090-2104"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biochemical and Biophysical Research Communications","raw_type":"journal-article"},{"id":"pmid:31954521","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31954521","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biochemical and biophysical research communications","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.bbrc.2019.12.094","doi":"https://doi.org/10.1016/j.bbrc.2019.12.094","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bbrc.2019.12.094","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0006291X20300310/pdf","source":{"id":"https://openalex.org/S151589183","display_name":"Biochemical and Biophysical Research Communications","issn_l":"0006-291X","issn":["0006-291X","1090-2104"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biochemical and Biophysical Research Communications","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8048999905586243,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3000299679.pdf","grobid_xml":"https://content.openalex.org/works/W3000299679.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W1968715156","https://openalex.org/W1972895358","https://openalex.org/W1974625077","https://openalex.org/W1979855662","https://openalex.org/W1997754945","https://openalex.org/W2001073773","https://openalex.org/W2024536332","https://openalex.org/W2028342121","https://openalex.org/W2033013069","https://openalex.org/W2034885939","https://openalex.org/W2039885485","https://openalex.org/W2053945089","https://openalex.org/W2057990302","https://openalex.org/W2105437577","https://openalex.org/W2107965372","https://openalex.org/W2119702047","https://openalex.org/W2141220224","https://openalex.org/W2145842706","https://openalex.org/W2212235774","https://openalex.org/W2403997508","https://openalex.org/W2603647167","https://openalex.org/W2608961468","https://openalex.org/W2810523701","https://openalex.org/W2939923831","https://openalex.org/W2943460586","https://openalex.org/W2950219014"],"related_works":["https://openalex.org/W4393085773","https://openalex.org/W7007877648","https://openalex.org/W7149105960","https://openalex.org/W7115032834","https://openalex.org/W2085697301","https://openalex.org/W4387576016","https://openalex.org/W2105437577","https://openalex.org/W7131646046","https://openalex.org/W6982287137"],"abstract_inverted_index":{"The":[0,178],"DEAD-box":[1,27,37,175],"family":[2],"of":[3,158,161,174,188,193],"RNA":[4,20,28,93,107,176],"helicases":[5],"plays":[6],"essential":[7],"roles":[8],"in":[9,44],"both":[10],"transcriptional":[11],"and":[12,36,48,62,81,112],"translational":[13],"mRNA":[14],"degradation;":[15],"they":[16],"unwind":[17],"short":[18],"double-stranded":[19],"by":[21],"breaking":[22],"the":[23,45,171,186,189],"RNA-RNA":[24],"interactions.":[25],"Two":[26],"helicases,":[29],"eukaryotic":[30],"translation":[31],"initiation":[32],"factor":[33],"4A3":[34],"(eIF4A3)":[35],"helicase":[38,94,108,137,164,190],"3":[39],"(DDX3X),":[40],"show":[41],"high":[42],"homology":[43],"ATP-binding":[46],"region":[47],"are":[49,76],"considered":[50],"key":[51],"molecules":[52,58],"for":[53,78,87,92,110,169],"cancer":[54,69,79],"progression.":[55],"Several":[56],"small":[57],"that":[59,142],"target":[60],"eIF4A3":[61,111,120,127,144],"DDX3X":[63,151,159],"have":[64],"been":[65],"reported":[66],"to":[67,90],"inhibit":[68],"cell":[70],"growth;":[71],"however,":[72],"more":[73],"potent":[74],"compounds":[75,141],"required":[77],"therapeutics,":[80],"there":[82],"is":[83],"a":[84,130,149],"critical":[85],"need":[86],"high-throughput":[88,106,179],"assays":[89,109,181],"screen":[91],"inhibitors.":[95],"In":[96],"this":[97],"study,":[98],"we":[99,117,147],"developed":[100],"novel":[101],"fluorescence":[102],"resonance":[103],"energy":[104],"transfer-based":[105],"DDX3X.":[113],"Using":[114],"these":[115],"assays,":[116],"identified":[118,148],"several":[119],"allosteric":[121],"inhibitors":[122,165],"whose":[123],"inhibitory":[124,134,191],"effect":[125,135],"on":[126,136],"ATPase":[128,145],"showed":[129,155],"strong":[131],"correlation":[132],"with":[133],"activity.":[138],"From":[139],"102":[140],"exhibited":[143],"inhibition,":[146],"selective":[150],"inhibitor,":[152],"C1,":[153],"which":[154],"stronger":[156],"inhibition":[157],"than":[160],"eIF4A3.":[162],"Small-molecule":[163],"can":[166],"be":[167],"valuable":[168],"clarifying":[170],"molecular":[172],"machinery":[173],"helicases.":[177],"quantitative":[180],"established":[182],"here":[183],"should":[184],"facilitate":[185],"evaluation":[187],"activity":[192],"compounds.":[194]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3000299679","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2020-01-23T00:00:00"}
